Stocks Hitting 52-Week Lows
Cell Therapeutics (NASDAQ: CTIC) shares fell 23.58% to touch a new 52-week low of $1.56. Cell Therapeutics priced an underwritten public offering of 60,000 shares of its Series 17 Preferred Stock at a price of $1,000 per share.
Cache (NASDAQ: CACH) shares dropped 20% to create a new 52-week low of $2.60. Cache expects a wider loss for the third quarter.
Summer Infant (NASDAQ: SUMR) shares lost 2.34% to create a new 52-week low of $1.67. Summer Infant shares have dropped 74.82% over the past 52 weeks, while the S&P 500 index has gained 26.48% in the same period.
O2Micro International Ltd (NASDAQ: OIIM) shares declined 3.11% to create a new 52-week low of $3.43. O2Micro cut its Q3 revenue forecast.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.